Syngen Biotech Statistics

Total Valuation

Syngen Biotech has a market cap or net worth of TWD 2.71 billion. The enterprise value is 2.56 billion.

Market Cap	2.71B
Enterprise Value	2.56B

Important Dates

The next estimated earnings date is Monday, May 4, 2026.

Earnings Date	May 4, 2026
Ex-Dividend Date	Jun 26, 2025

Share Statistics

Syngen Biotech has 27.10 million shares outstanding. The number of shares has increased by 2.61% in one year.

Current Share Class	27.10M
Shares Outstanding	27.10M
Shares Change (YoY)	+2.61%
Shares Change (QoQ)	+22.92%
Owned by Insiders (%)	7.00%
Owned by Institutions (%)	3.25%
Float	10.96M

Valuation Ratios

The trailing PE ratio is 11.42.

PE Ratio	11.42
Forward PE	n/a
PS Ratio	1.31
PB Ratio	1.19
P/TBV Ratio	1.21
P/FCF Ratio	8.36
P/OCF Ratio	7.24
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.16, with an EV/FCF ratio of 7.88.

EV / Earnings	10.48
EV / Sales	1.24
EV / EBITDA	6.16
EV / EBIT	8.51
EV / FCF	7.88

Financial Position

The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.07.

Current Ratio	1.84
Quick Ratio	1.10
Debt / Equity	0.07
Debt / EBITDA	0.40
Debt / FCF	0.51
Interest Coverage	58.61

Financial Efficiency

Return on equity (ROE) is 11.00% and return on invested capital (ROIC) is 10.80%.

Return on Equity (ROE)	11.00%
Return on Assets (ROA)	6.04%
Return on Invested Capital (ROIC)	10.80%
Return on Capital Employed (ROCE)	12.21%
Weighted Average Cost of Capital (WACC)	5.51%
Revenue Per Employee	8.37M
Profits Per Employee	987,170
Employee Count	247
Asset Turnover	0.67
Inventory Turnover	3.55

Taxes

In the past 12 months, Syngen Biotech has paid 57.20 million in taxes.

Income Tax	57.20M
Effective Tax Rate	19.00%

Stock Price Statistics

The stock price has decreased by -18.70% in the last 52 weeks. The beta is 0.26, so Syngen Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.26
52-Week Price Change	-18.70%
50-Day Moving Average	111.98
200-Day Moving Average	121.01
Relative Strength Index (RSI)	23.19
Average Volume (20 Days)	21,104

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Syngen Biotech had revenue of TWD 2.07 billion and earned 243.83 million in profits. Earnings per share was 8.76.

Revenue	2.07B
Gross Profit	687.05M
Operating Income	296.08M
Pretax Income	301.03M
Net Income	243.83M
EBITDA	398.79M
EBIT	296.08M
Earnings Per Share (EPS)	8.76

Full Income Statement

Balance Sheet

The company has 319.87 million in cash and 165.63 million in debt, giving a net cash position of 154.24 million or 5.69 per share.

Cash & Cash Equivalents	319.87M
Total Debt	165.63M
Net Cash	154.24M
Net Cash Per Share	5.69
Equity (Book Value)	2.27B
Book Value Per Share	68.05
Working Capital	537.53M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 374.32 million and capital expenditures -49.98 million, giving a free cash flow of 324.34 million.

Operating Cash Flow	374.32M
Capital Expenditures	-49.98M
Depreciation & Amortization	102.71M
Net Borrowing	-183.40M
Free Cash Flow	324.34M
FCF Per Share	11.97

Full Cash Flow Statement

Margins

Gross margin is 33.24%, with operating and profit margins of 14.32% and 11.80%.

Gross Margin	33.24%
Operating Margin	14.32%
Pretax Margin	14.56%
Profit Margin	11.80%
EBITDA Margin	19.29%
EBIT Margin	14.32%
FCF Margin	15.69%

Dividends & Yields

This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 4.88%.

Dividend Per Share	5.00
Dividend Yield	4.88%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	55.57%
Buyback Yield	-2.61%
Shareholder Yield	2.27%
Earnings Yield	9.00%
FCF Yield	11.97%

Dividend Details

Stock Splits

The last stock split was on July 9, 2018. It was a forward split with a ratio of 1.1.

Last Split Date	Jul 9, 2018
Split Type	Forward
Split Ratio	1.1

Scores

Altman Z-Score	n/a
Piotroski F-Score	6